2-Hydroxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzaldehyde, 97%, 250mg

3-p-Tolyl-1H-pyrazole-4-carbaldehyde, 95.0%, 1g

Solución de hidróxido de sodio al 0,5%, 0,5%, extra pura, 2,5 l, envase de plástico.

Fmoc-L-Leucine, PEPTIPURE®, mínimo 95 %, para bioquímica, 50 g, envase de vidrio

1,5-Diisocyanatonaphthalene>98.0%(GC)100g

1-(4-Bromothiazol-2-yl)ethanone, 97.0%, 100mg

Ethyl 3-(1H-pyrazol-3-yl)indolizine-1-carboxylate, 95%, 1g

Ethyl 2-(6-chloropyridin-3-yl)acetate, 95.0%, 5g

2-BROMO-6-(PIPERIDIN-4-YL)PYRIDINE HCL, 95.0%, 1g

5,7-Dichloro-2-methylthiazolo[5,4-d]pyrimidine, 95.0%, 100mg

1-(3-Aminobenzenesulfonyl)piperidin-4-ol, 95%, 250mg

Ethyl 1-formyl-4-oxo-4H-quinolizine-3-carboxylate, 95.0%, 250mg

4-Propylbenzene-1,2-diol, 98%, 250mg